StockData
EoCene Ltd. logo

EoCene Ltd. (EOCN) stock

EOCNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 31, 2026Score 5/30
$2.46−0.07 (-2.77%)

Close on Nov 17, 2026Market cap $2.46MP/E –Yield –

EoCene operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

EoCene's operating cash flow for the twelve months ending Dec 31, 2025 was -$6.32M. For fiscal 2025 it was -$6.32M. The highest annual figure on record is -$2.52M in fiscal 2013.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$6.32M–
FY2024Dec 31, 2024-$5.88M–
FY2023Dec 31, 2023-$6.14M–
FY2022Dec 31, 2022-$18.50M–
FY2021Dec 31, 2021-$32.89M–
FY2020Dec 31, 2020-$26.29M–
FY2019Dec 31, 2019-$14.94M–
FY2018Dec 31, 2018-$9.02M–
FY2017Dec 31, 2017-$12.07M–
FY2016Dec 31, 2016-$12.13M–
FY2015Dec 31, 2015-$8.47M–
FY2014Dec 31, 2014-$9.24M–
FY2013Dec 31, 2013-$2.52M–
FY2012Dec 31, 2012-$3.08M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2025Dec 31, 2025-$1.95M–
Q3 FY2025Sep 30, 2025-$1.94M–
Q4 FY2024Dec 31, 2024-$1.91M–
Q3 FY2024Sep 30, 2024-$1.13M–

More EoCene figures

See a number that looks wrong?